Keishiro Aoyagi Selected Research

Keishiro Aoyagi Research Topics

Disease

22	Stomach Neoplasms (Stomach Cancer) 01/2024 - 01/2002
10	Neoplasms (Cancer) 10/2020 - 01/2002
7	Neoplasm Metastasis (Metastasis) 12/2015 - 10/2004
2	Lymphatic Metastasis 08/2022 - 01/2012
2	Carcinoma (Carcinomatosis) 03/2013 - 01/2003
2	Ascites 09/2010 - 02/2007
1	Edema (Dropsy) 01/2024
1	Hemorrhage 08/2022
1	Postgastrectomy Syndromes 03/2017
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2015
1	Small Cell Carcinoma 12/2015
1	Colorectal Neoplasms (Colorectal Cancer) 10/2014
1	Weight Loss (Weight Reduction) 01/2014
1	Hypoxia (Hypoxemia) 04/2013
1	Adenoma (Adenomas) 01/2013
1	Adenocarcinoma 01/2013
1	Brain Neoplasms (Brain Tumor) 10/2004
1	Familial primary gastric lymphoma 07/2002

Drug/Important Bio-Agent (IBA)

6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2014 - 01/2005
3	Cisplatin (Platino)FDA LinkGeneric 12/2015 - 01/2002
3	Bevacizumab (Avastin)FDA Link 10/2014 - 09/2010
2	Proteins (Proteins, Gene)FDA Link 01/2024 - 10/2014
2	Messenger RNA (mRNA)IBA 08/2022 - 01/2014
2	Monoclonal AntibodiesIBA 11/2013 - 09/2010
2	Indicators and Reagents (Reagents)IBA 04/2013 - 01/2005
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2003 - 07/2002
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2003 - 01/2002
1	Keratin-20 (Cytokeratin 20)IBA 08/2022
1	Cell Adhesion MoleculesIBA 08/2022
1	Carcinoembryonic AntigenIBA 08/2022
1	Adapalene (Differin)FDA LinkGeneric 07/2020
1	Taxoids (Taxanes)IBA 12/2015
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2015
1	Docetaxel (Taxotere)FDA Link 12/2015
1	amrubicinIBA 12/2015
1	Carboplatin (JM8)FDA LinkGeneric 12/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2015
1	Etoposide (VP 16)FDA LinkGeneric 12/2015
1	human ERBB2 proteinIBA 10/2014
1	Cetuximab (Erbitux)FDA Link 10/2014
1	Trastuzumab (Herceptin)FDA Link 10/2014
1	Panitumumab (Vectibix)FDA Link 10/2014
1	RamucirumabIBA 10/2014
1	Vascular Endothelial Growth FactorsIBA 10/2014
1	EGF Family of ProteinsIBA 10/2014
1	N 30IBA 01/2014
1	GhrelinIBA 01/2014
1	EnzymesIBA 01/2014
1	ImmunosorbentsIBA 01/2014
1	Transcription Factors (Transcription Factor)IBA 04/2013
1	Oxygen (Dioxygen)IBA 04/2013
1	ParaffinIBA 04/2013
1	Glucose (Dextrose)FDA LinkGeneric 04/2013
1	Cyclin-Dependent Kinase Inhibitor p27IBA 03/2013
1	Interleukin-8 (Interleukin 8)IBA 01/2011
1	Interleukin-6 (Interleukin 6)IBA 01/2011
1	Fibronectins (Fibronectin)IBA 01/2011
1	Tissue Inhibitor of Metalloproteinase-1IBA 02/2007
1	Peroxidase (Myeloperoxidase)IBA 01/2005
1	AvidinIBA 01/2005
1	Biotin (Vitamin H)FDA Link 01/2005
1	doxifluridineIBA 10/2004
1	titanium silicide (TS-1)IBA 10/2004
1	DNA (Deoxyribonucleic Acid)IBA 01/2003
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2003
1	RNA (Ribonucleic Acid)IBA 01/2003
1	deoxyuridine triphosphateIBA 07/2002
1	TransferasesIBA 07/2002
1	Amyloid (Amyloid Fibrils)IBA 01/2002
1	Fluorouracil (Carac)FDA LinkGeneric 01/2002

Therapy/Procedure

15	Gastrectomy 01/2024 - 02/2010
5	Therapeutics 12/2015 - 10/2004
1	Operative Time 01/2024
1	Gastroenterostomy 01/2024
1	Combined Modality Therapy 12/2015
1	Drug Therapy (Chemotherapy) 01/2014
1	Neoadjuvant Therapy 10/2013
1	Lymph Node Excision (Lymph Node Dissection) 01/2012
1	Operative Surgical Procedures 01/2012
1	Splenectomy 02/2010
1	Aftercare (After-Treatment) 01/2002